Signal Advance, Inc (SIGL)

[trendmkr]

$13 billion projected growth in cardiac rhythm management

“A new report by Visiongain, a London-based business information provider predicts the global cardiac rhythm management market to be worth $27.8bn by 2021. The market generated $14.6bn in 2010.” [1]

This represents $13.2bn projected growth in revenues over ten years. Cardiac rhythm management includes cardiac pacing, implantable defibrillators, cardiac resynchronization and resynchronization therapy defibrillators.

“The global market for neurostimulation devices market was valued at about $1.85 billion in the year 2009. It is expected to reach a size of $4.9 billion by 2016 with a Compound Annual Growth Rate (CAGR) of 15% from 2009 to 2016.”